Autonomic side effects of botulinum toxin type B therapy.
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000378:metabolism; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D001905:Botulinum Toxins / Q000009:adverse effects* / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006945:Hyperhidrosis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D013997:Time Factors; D014103:Torticollis / Q000145:classification / Q000188:drug therapy* / Q000276:immunology; D014987:Xerostomia / Q000139:chemically induced
D000906:Antibodies; D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A